Elite Wealth Management, Inc. Pfizer Inc Transaction History

Elite Wealth Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $13,544 - $15,671	-375 Reduced 6.3%	5,573 $204,000
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $7,306 - $9,537	175 Added 3.03%	5,948 $304,000
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $9,306 - $11,034	200 Added 3.59%	5,773 $303,000
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $457 - $566	-10 Reduced 0.18%	5,573 $289,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $230,689 - $341,958	5,583 New	5,583 $330,000
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $179,885 - $205,089	-4,676 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $34,470 - $41,810	-1,000 Reduced 17.62%	4,676 $206,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $3,191 - $3,702	-100 Reduced 1.73%	5,676 $201,000
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $192,109 - $203,835	5,776	5,776 $209,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Elite Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Elite Wealth Management, Inc. with notifications on news.